Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
3.50 Down 0.06(1.69%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:3.56
Open:3.53
Bid:N/A
Ask:5.52 x 30000
1y Target Est:9.50
Beta:1.64
Next Earnings Date:N/A
Day's Range:3.44 - 3.73
52wk Range:3.20 - 7.45
Volume:886,850
Avg Vol (3m):1,444,130
Market Cap:243.51M
P/E (ttm):N/A
EPS (ttm):-0.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 1.69%243.51M
DNDNDown 1.49%406.39M
NKTRDown 0.68%1.39B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.37
Quarterly EPS Est (Mar-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback